Clinical Trial: Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surgery

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750418) titled 'Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surger... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More

Clinical Trial: Comparison Between Low-Dose and High-Dose Nepafenac Sodium

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749027) titled 'Comparison Between Low-Dose and High-Dose Nepafenac Sodium' on July 31. Brief Summary: In S... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... Read More

Clinical Trial: Acceptance and Commitment Therapy (ACT) Versus Cognitive Behavioural Therapy (CBT) for Fear of Cancer Recurrence (FCR) in Cancer Survivors and Their Spouses

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749560) titled 'Acceptance and Commitment Therapy (ACT) Versus Cognitive Behavioural Therapy (CBT) for Fear ... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... Read More

Clinical Trial: Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748858) titled 'Improving Patient-Centered Care for Underserved Older African American Patients With Cardiov... Read More

Clinical Trial: ZEPU AI9 Exoskeleton Rehabilitation Robot

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750808) titled 'ZEPU AI9 Exoskeleton Rehabilitation Robot' on Aug. 02. Brief Summary: The goal of this clin... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and e... Read More

• ««
• «
• 1330
• 1331
• 1332
• 1333
• 1334
• 1335
• 1336
• 1337
• 1338
• 1339
• »
• »»